Skip to main content
main-content

28.09.2022 | Original Article

Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial

verfasst von: Sehresh Hassan, Mohsin Shah, Muhammad Omar Malik, Ehtesham Ehtesham, Syed Hamid Habib, Bushra Rauf

Erschienen in: Endocrine

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The present study aimed to assess whether treatment with combined resveratrol and myoinositol is more effective in ameliorating the altered parameters associated with PCOS when compared to the combined metformin and pioglitazone therapy.

Method

One hundred and ten obese, oligo-anovulatory PCOS women, aged 20–35 years were randomly assigned into two treatment arms. Participants in arm-1 (n = 55), received combination of metformin and pioglitazone (500 mg and 15 mg, respectively), twice daily, while those in arm-2 (n = 55) received combination of resveratrol and myoinositol (1000 mg and 1000 mg, respectively) twice daily for 12 weeks. Evaluations performed at baseline were repeated after 3 months of therapy. The endocrine and metabolic derangements were assessed by measuring serum levels of testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), adiponectin and insulin using ELISA. Cohen’s perceived stress scale (PSS) was employed as a subjective measure of stress.

Results

Pre-treatment PCOS women in both the arms (arm-1 and arm-2) had remarkably elevated serum testosterone and insulin concentrations, low serum adiponectin and high perceived stress response scores. The treatment reduced the altered endocrine indices in arm-2 (resveratrol and myoinositol) participants, manifested by statistically significant reduction in serum testosterone level (p = 0.001) and notably increased serum adiponectin level (p = 0.001). Interestingly, the hormonal profile, including serum LH and FSH levels also decreased (p < 0.001) along with a marked reduction in the ovarian volume (p = 0.001) in arm-2 participants. There was a significant reduction in weight (<0.001), BMI (p < 0.001) and an improvement in waist-hip ratio (p < 0.001) in arm-2 participants compared to arm-1 group. The PSS scores of the arm-2 subjects improved significantly (p < 0.001) whereas, the Ferrimen-Gallwey score was improved in both the arms (arm-1 and arm-2; p = 0.010 and 0.008 respectively) however, the change was highly significant in arm-2. Interestingly, the menstrual regularity was 81.4% in arm-2 while 18.2% in arm-1. We conclude that the therapeutic intervention with combined resveratrol and myoinositol is more effective in ameliorating altered endocrine, metabolic indices and stress burden and could be of clinical importance in high risk group of obese, oligo-anovulatory married PCOS affected women.

Trial registration

ClinicalTials.gov Trial No: NCT04867252. Registered 24 April, 2021, https://​clinicaltrials.​gov/​ct2/​show/​NCT04867252
Literatur
2.
Zurück zum Zitat M. Bani Mohammad, A. Majdi Seghinsara, Polycystic Ovary Syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac. J. Cancer Prev. APJCP 18(1), 17–21 (2017) PubMed M. Bani Mohammad, A. Majdi Seghinsara, Polycystic Ovary Syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac. J. Cancer Prev. APJCP 18(1), 17–21 (2017) PubMed
3.
Zurück zum Zitat M. Mirabelli, E. Chiefari, B. Arcidiacono, D.M. Corigliano, F.S. Brunetti, V. Maggisano, D. Russo, D.P. Foti, A. Brunetti, Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients 12(4), 1066 (2020). PubMedCentralCrossRef M. Mirabelli, E. Chiefari, B. Arcidiacono, D.M. Corigliano, F.S. Brunetti, V. Maggisano, D. Russo, D.P. Foti, A. Brunetti, Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients 12(4), 1066 (2020). PubMedCentralCrossRef
4.
Zurück zum Zitat S. Guo, Q. Yao, Z. Ke, H. Chen, J. Wu, C. Liu, Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol. Cell Endocrinol. 412, 85–94 (2015) PubMedCrossRef S. Guo, Q. Yao, Z. Ke, H. Chen, J. Wu, C. Liu, Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol. Cell Endocrinol. 412, 85–94 (2015) PubMedCrossRef
5.
Zurück zum Zitat K. Szkudelska, T. Szkudelski, Resveratrol, obesity and diabetes. Eur. J. Pharmacol. 635(1), 1–8 (2010) PubMedCrossRef K. Szkudelska, T. Szkudelski, Resveratrol, obesity and diabetes. Eur. J. Pharmacol. 635(1), 1–8 (2010) PubMedCrossRef
6.
Zurück zum Zitat B. Salehi, A.P. Mishra, M. Nigam, B. Sener, M. Kilic, M. Sharifi-Rad, P.V. Tsouh Fokou, N. Martins, A Double-Edged Sword in Health Benefits. Biomedicine 6(3), 91 (2018). B. Salehi, A.P. Mishra, M. Nigam, B. Sener, M. Kilic, M. Sharifi-Rad, P.V. Tsouh Fokou, N. Martins, A Double-Edged Sword in Health Benefits. Biomedicine 6(3), 91 (2018).
8.
Zurück zum Zitat C. Tatone, G. Di Emidio, M. Vitti, M. Di Carlo, S. Santini, A.M. D’Alessandro, S. Falone, F. Amicarelli, Sirtuin functions in female fertility: possible role in oxidative stress and aging. Oxid. Med. Cell. Longev. 2015, 659687 (2015) PubMedPubMedCentralCrossRef C. Tatone, G. Di Emidio, M. Vitti, M. Di Carlo, S. Santini, A.M. D’Alessandro, S. Falone, F. Amicarelli, Sirtuin functions in female fertility: possible role in oxidative stress and aging. Oxid. Med. Cell. Longev. 2015, 659687 (2015) PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat P.-A. Regidor, A.E. Schindler, Myoinositol as a safe and alternative approach in the treatment of infertile PCOS women: a German observational study. Int. J. Endocrinol. 2016, 9537632 (2016) PubMedPubMedCentralCrossRef P.-A. Regidor, A.E. Schindler, Myoinositol as a safe and alternative approach in the treatment of infertile PCOS women: a German observational study. Int. J. Endocrinol. 2016, 9537632 (2016) PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat S. Suzuki, H. Kawasaki, Y. Satoh, M. Ohtomo, M. Hirai, A. Hirai, S. Hirai, M. Onoda, M. Matsumoto, Y. Hinokio et al. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care 17(12), 1465–1468 (1994) PubMedCrossRef S. Suzuki, H. Kawasaki, Y. Satoh, M. Ohtomo, M. Hirai, A. Hirai, S. Hirai, M. Onoda, M. Matsumoto, Y. Hinokio et al. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care 17(12), 1465–1468 (1994) PubMedCrossRef
11.
Zurück zum Zitat M.F. Gangale, L. Miele, A. Lanzone, F. Sagnella, D. Martinez, A. Tropea, F. Moro, A. Morciano, A. Ciardulli, C. Palla, M. Pompili, C. Cefalo, A. Grieco, R. Apa, Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. Clin. Endocrinol. 75(4), 520–527 (2011) CrossRef M.F. Gangale, L. Miele, A. Lanzone, F. Sagnella, D. Martinez, A. Tropea, F. Moro, A. Morciano, A. Ciardulli, C. Palla, M. Pompili, C. Cefalo, A. Grieco, R. Apa, Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. Clin. Endocrinol. 75(4), 520–527 (2011) CrossRef
12.
Zurück zum Zitat U. Smith, Pioglitazone: mechanism of action. Int J. Clin. Pr. Suppl. 121, 13–18 (2001) U. Smith, Pioglitazone: mechanism of action. Int J. Clin. Pr. Suppl. 121, 13–18 (2001)
13.
Zurück zum Zitat M. Zahra, M. Shah, A. Ali, R. Rahim, Effects of metformin on endocrine and metabolic parameters in patients with polycystic ovary syndrome. Horm. Metab. Res. 49(2), 103–108 (2017) PubMed M. Zahra, M. Shah, A. Ali, R. Rahim, Effects of metformin on endocrine and metabolic parameters in patients with polycystic ovary syndrome. Horm. Metab. Res. 49(2), 103–108 (2017) PubMed
14.
Zurück zum Zitat S. Tauqir, M. Israr, B. Rauf, M.O. Malik, S.H. Habib, F.A. Shah, M. Usman, M.A. Raza, I. Shah, H. Badshah, E. Ehtesham, M. Shah, Acetyl-L-carnitine ameliorates metabolic and endocrine alterations in women with PCOS: a double-blind randomized clinical. Trial 38(7), 3842–3856 (2021) S. Tauqir, M. Israr, B. Rauf, M.O. Malik, S.H. Habib, F.A. Shah, M. Usman, M.A. Raza, I. Shah, H. Badshah, E. Ehtesham, M. Shah, Acetyl-L-carnitine ameliorates metabolic and endocrine alterations in women with PCOS: a double-blind randomized clinical. Trial 38(7), 3842–3856 (2021)
15.
Zurück zum Zitat R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit, O.E. Janssen, R.S. Legro, R.J. Norman, A.E. Taylor, S.F. Witchel, The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91(2), 456–488 (2009) PubMedCrossRef R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit, O.E. Janssen, R.S. Legro, R.J. Norman, A.E. Taylor, S.F. Witchel, The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91(2), 456–488 (2009) PubMedCrossRef
16.
Zurück zum Zitat M. Luque-Ramírez, F. Alvarez-Blasco, H.F. Escobar-Morreale, Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients. Obesity 17(1), 3–9 (2009) PubMedCrossRef M. Luque-Ramírez, F. Alvarez-Blasco, H.F. Escobar-Morreale, Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients. Obesity 17(1), 3–9 (2009) PubMedCrossRef
17.
Zurück zum Zitat B. Banaszewska, J. Wrotyńska-Barczyńska, R.Z. Spaczynski, L. Pawelczyk, A.J. Duleba, Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 101(11), 4322–4328 (2016) PubMedCrossRef B. Banaszewska, J. Wrotyńska-Barczyńska, R.Z. Spaczynski, L. Pawelczyk, A.J. Duleba, Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 101(11), 4322–4328 (2016) PubMedCrossRef
18.
Zurück zum Zitat R. Aswini, S. Jayapalan, Modified Ferriman-Gallwey score in hirsutism and its association with metabolic syndrome. Int J. Trichol. 9(1), 7–13 (2017) CrossRef R. Aswini, S. Jayapalan, Modified Ferriman-Gallwey score in hirsutism and its association with metabolic syndrome. Int J. Trichol. 9(1), 7–13 (2017) CrossRef
19.
Zurück zum Zitat F. Orio Jr., S. Palomba, T. Cascella, G. Milan, R. Mioni, C. Pagano, F. Zullo, A. Colao, G. Lombardi, R. Vettor, Adiponectin levels in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88(6), 2619–2623 (2003) PubMedCrossRef F. Orio Jr., S. Palomba, T. Cascella, G. Milan, R. Mioni, C. Pagano, F. Zullo, A. Colao, G. Lombardi, R. Vettor, Adiponectin levels in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88(6), 2619–2623 (2003) PubMedCrossRef
20.
Zurück zum Zitat D. Panidis, A. Kourtis, D. Farmakiotis, T. Mouslech, D. Rousso, G. Koliakos, Serum adiponectin levels in women with polycystic ovary syndrome. Hum. Reprod. 18(9), 1790–1796 (2003) PubMedCrossRef D. Panidis, A. Kourtis, D. Farmakiotis, T. Mouslech, D. Rousso, G. Koliakos, Serum adiponectin levels in women with polycystic ovary syndrome. Hum. Reprod. 18(9), 1790–1796 (2003) PubMedCrossRef
21.
Zurück zum Zitat J. Tomé-Carneiro, M. Gonzálvez, M. Larrosa, M.J. Yáñez-Gascón, F.J. García-Almagro, J.A. Ruiz-Ros, F.A. Tomás-Barberán, M.T. García-Conesa, J.C. Espín, Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 27(1), 37–48 (2013) PubMedCrossRef J. Tomé-Carneiro, M. Gonzálvez, M. Larrosa, M.J. Yáñez-Gascón, F.J. García-Almagro, J.A. Ruiz-Ros, F.A. Tomás-Barberán, M.T. García-Conesa, J.C. Espín, Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 27(1), 37–48 (2013) PubMedCrossRef
22.
Zurück zum Zitat M. Wiciński, B. Malinowski, M.M. Węclewicz, E. Grześk, G. Grześk, Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model. Exp. therapeutic Med. 13(5), 2071–2078 (2017) CrossRef M. Wiciński, B. Malinowski, M.M. Węclewicz, E. Grześk, G. Grześk, Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model. Exp. therapeutic Med. 13(5), 2071–2078 (2017) CrossRef
23.
Zurück zum Zitat S. M. Mousavi, A. Milajerdi, Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials. Obes Rev. 20(3), 487–498 (2019) S. M. Mousavi, A. Milajerdi, Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials. Obes Rev. 20(3), 487–498 (2019)
24.
Zurück zum Zitat F. Corrado, R. D’Anna, G. Di Vieste, D. Giordano, B. Pintaudi, A. Santamaria, Di, A. Benedetto, The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet. Med. J. Br. Diabet. Assoc. 28(8), 972–975 (2011) CrossRef F. Corrado, R. D’Anna, G. Di Vieste, D. Giordano, B. Pintaudi, A. Santamaria, Di, A. Benedetto, The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet. Med. J. Br. Diabet. Assoc. 28(8), 972–975 (2011) CrossRef
25.
Zurück zum Zitat V.Soldat-Stankovic, S.Popovic-Pejicic, S.Stankovic, A.Prtina, G.Malesevic, J.Bjekic-Macut, S.Livadas, S.Ognjanovic, G.Mastorakos, D.Micic, D.Macut, The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. J Endocrinol Invest 45(3), 583–595 (2022) PubMedCrossRef V.Soldat-Stankovic, S.Popovic-Pejicic, S.Stankovic, A.Prtina, G.Malesevic, J.Bjekic-Macut, S.Livadas, S.Ognjanovic, G.Mastorakos, D.Micic, D.Macut, The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. J Endocrinol Invest 45(3), 583–595 (2022) PubMedCrossRef
26.
Zurück zum Zitat X. Duan, M. Zhou, G. Zhou, Q. Zhu, W. Li, Effect of metformin on adiponectin in PCOS: a meta-analysis and a systematic review. Eur. J. Obstet., Gynecol. Reprod. Biol. 267, 61–67 (2021) CrossRef X. Duan, M. Zhou, G. Zhou, Q. Zhu, W. Li, Effect of metformin on adiponectin in PCOS: a meta-analysis and a systematic review. Eur. J. Obstet., Gynecol. Reprod. Biol. 267, 61–67 (2021) CrossRef
27.
Zurück zum Zitat M. Le Donne, D. Metro, A. Alibrandi, M. Papa, S. Benvenga, Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome. Eur. Rev. Med Pharm. Sci. 23(5), 2293–2301 (2019) M. Le Donne, D. Metro, A. Alibrandi, M. Papa, S. Benvenga, Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome. Eur. Rev. Med Pharm. Sci. 23(5), 2293–2301 (2019)
28.
Zurück zum Zitat B. Pangaribuan, I. Yusuf, M. Mansyur, A. Wijaya, Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 2(6), 235–245 (2011) PubMedPubMedCentralCrossRef B. Pangaribuan, I. Yusuf, M. Mansyur, A. Wijaya, Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 2(6), 235–245 (2011) PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, S. Rahe, H. Staiger, E. Maerker, H. Häring, M. Stumvoll, Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52(2), 239–243 (2003) PubMedCrossRef O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, S. Rahe, H. Staiger, E. Maerker, H. Häring, M. Stumvoll, Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52(2), 239–243 (2003) PubMedCrossRef
30.
Zurück zum Zitat M.Bahramrezaie, F.Amidi, Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. Sci Rep 36(8), 1701–1712 (2019) M.Bahramrezaie, F.Amidi, Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. Sci Rep 36(8), 1701–1712 (2019)
31.
Zurück zum Zitat A. Pizzo, A.S. Laganà, L. Barbaro, Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol. Endocrinol. 30(3), 205–208 (2014) PubMedCrossRef A. Pizzo, A.S. Laganà, L. Barbaro, Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol. Endocrinol. 30(3), 205–208 (2014) PubMedCrossRef
32.
Zurück zum Zitat E. Kousta, D.M. White, E. Cela, M.I. McCarthy, S. Franks, The prevalence of polycystic ovaries in women with infertility. Hum. Reprod. 14(11), 2720–2723 (1999) PubMedCrossRef E. Kousta, D.M. White, E. Cela, M.I. McCarthy, S. Franks, The prevalence of polycystic ovaries in women with infertility. Hum. Reprod. 14(11), 2720–2723 (1999) PubMedCrossRef
33.
Zurück zum Zitat A. Benrick, M. Maliqueo, S. Miao, J.A. Villanueva, Y. Feng, C. Ohlsson, A.J. Duleba, E. Stener-Victorin, Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic ovary syndrome. Evid. Based Complement Altern. Med 2013, 964070 (2013) CrossRef A. Benrick, M. Maliqueo, S. Miao, J.A. Villanueva, Y. Feng, C. Ohlsson, A.J. Duleba, E. Stener-Victorin, Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic ovary syndrome. Evid. Based Complement Altern. Med 2013, 964070 (2013) CrossRef
34.
Zurück zum Zitat A. Mansour, M. Samadi, M. Sanginabadi, H. Gerami, S. Karimi, S. Hosseini, N. Shirzad, A. Hekmatdoost, A. Mahdavi-Gorabi, M.R. Mohajeri-Tehrani, M. Qorbani, Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS. Clin. Nutr. 40(6), 4106–4112 (2021) PubMedCrossRef A. Mansour, M. Samadi, M. Sanginabadi, H. Gerami, S. Karimi, S. Hosseini, N. Shirzad, A. Hekmatdoost, A. Mahdavi-Gorabi, M.R. Mohajeri-Tehrani, M. Qorbani, Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS. Clin. Nutr. 40(6), 4106–4112 (2021) PubMedCrossRef
35.
Zurück zum Zitat E. Papaleo, V. Unfer, J.P. Baillargeon, L. De Santis, F. Fusi, C. Brigante, G. Marelli, I. Cino, A. Redaelli, A. Ferrari, Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol. Endocrinol. 23(12), 700–703 (2007) PubMedCrossRef E. Papaleo, V. Unfer, J.P. Baillargeon, L. De Santis, F. Fusi, C. Brigante, G. Marelli, I. Cino, A. Redaelli, A. Ferrari, Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol. Endocrinol. 23(12), 700–703 (2007) PubMedCrossRef
36.
Zurück zum Zitat R.M. Ortega, C. Pérez-Rodrigo, A.M. López-Sobaler, Dietary assessment methods: dietary records. Nutr. Hosp. 31(Suppl 3), 38–45 (2015) PubMed R.M. Ortega, C. Pérez-Rodrigo, A.M. López-Sobaler, Dietary assessment methods: dietary records. Nutr. Hosp. 31(Suppl 3), 38–45 (2015) PubMed
37.
Zurück zum Zitat A.Hoseini, G.Namazi, A.Farrokhian, Z.Reiner, E.Aghadavod, F.Bahmani, Z.Asemi, The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food Funct 10, 6042–6051 (2019) PubMedCrossRef A.Hoseini, G.Namazi, A.Farrokhian, Z.Reiner, E.Aghadavod, F.Bahmani, Z.Asemi, The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food Funct 10, 6042–6051 (2019) PubMedCrossRef
38.
Zurück zum Zitat D. Costantino, G. Minozzi, E. Minozzi, C. Guaraldi, Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur. Rev. Med. Pharmacol. Sci. 13, 105–110 (2009) PubMed D. Costantino, G. Minozzi, E. Minozzi, C. Guaraldi, Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur. Rev. Med. Pharmacol. Sci. 13, 105–110 (2009) PubMed
39.
Zurück zum Zitat J.A. Barry, A.R. Kuczmierczyk, P.J. Hardiman, Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. 26(9), 2442–2451 (2011) PubMedCrossRef J.A. Barry, A.R. Kuczmierczyk, P.J. Hardiman, Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. 26(9), 2442–2451 (2011) PubMedCrossRef
40.
Zurück zum Zitat T. Liu, Y. Ma, R. Zhang, H. Zhong, L. Wang, J. Zhao, L. Yang, X. Fan, Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice. Psychopharmacology 236(4), 1385–1399 (2019) PubMedCrossRef T. Liu, Y. Ma, R. Zhang, H. Zhong, L. Wang, J. Zhao, L. Yang, X. Fan, Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice. Psychopharmacology 236(4), 1385–1399 (2019) PubMedCrossRef
Metadaten
Titel
Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial
verfasst von
Sehresh Hassan
Mohsin Shah
Muhammad Omar Malik
Ehtesham Ehtesham
Syed Hamid Habib
Bushra Rauf
Publikationsdatum
28.09.2022
Verlag
Springer US
Erschienen in
Endocrine
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03198-2

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.